Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?

The pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has led to an extraordinary threat to the global healthcare system. This infection disease, named COVID-19, is characterized by a wide clinical spectrum, ranging from asymptomatic or mild upper respiratory tract...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Giovanni A., Sacco, Oliviero, Capizzi, Antonino, Mastromarino, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172170/
https://www.ncbi.nlm.nih.gov/pubmed/34093569
http://dx.doi.org/10.3389/fimmu.2021.670955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172170/
https://www.ncbi.nlm.nih.gov/pubmed/34093569
http://dx.doi.org/10.3389/fimmu.2021.670955

Ejemplares similares